PMID: 9188368Sep 1, 1996Paper

Ten years of Orthoclone OKT3 (muromonab-CD3): a review

Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (NATCO)
S L Smith

Abstract

Many important advances in transplantation have been made during the last decade. The introduction of Orthoclone OKT3 into clinical trials and its subsequent approval by the Food and Drug Administration in 1985 for use as an antirejection agent for renal transplantation were landmarks in the field of clinical transplantation of solid organs. In the decade since the approval of OKT3 for clinical use, much has been learned and written about OKT3. OKT3 now is considered a safe and effective agent for prophylaxis and first-line treatment of acute rejection of solid organ allografts. In this article, the development and use of OKT3 over the last 10 years, as well as the present status and future implications of immune therapy with OKT3, are reviewed.

References

Sep 3, 1992·The New England Journal of Medicine·D AbramowiczM Goldman
Jan 1, 1992·Transplantation·M R FirstP Weiskittel
Sep 1, 1991·The Journal of International Medical Research·C SpiekerK H Rahn
Dec 20, 1990·The New England Journal of Medicine·I Penn
Jan 1, 1990·Transplantation·T J SchroederW F Ballistreri
Mar 1, 1989·Transplantation·B Husberg, G Klintmalm
Feb 1, 1988·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D J NormanB Hubert
Feb 1, 1988·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C F Shield, D J Norman
Jan 1, 1987·Nephron·A B Cosimi
Feb 1, 1987·Transplantation·J R ThistlethwaiteF P Stuart
Oct 22, 1970·The New England Journal of Medicine·T E StarzlC G Halgrimson
Dec 1, 1981·Transplantation·A B CosimiP S Russell
Dec 1, 1994·Kidney International·D AbramowiczP Vereerstraeten
Dec 1, 1994·Kidney International·F J BemelmanI J ten Berge
Sep 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·W J GaughanJ F Burke
Jan 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·T J Schroeder, M R First
Feb 1, 1993·Transplantation·T J SchroederP Pouletty

❮ Previous
Next ❯

Citations

May 12, 2009·Expert Opinion on Biological Therapy·Juliet EmamaulleeA M James Shapiro
Jan 26, 2016·Seminars in Cell & Developmental Biology·Tamara S RodemsDeric L Wheeler
Jan 30, 2016·The AAPS Journal·Boris GorovitsLi Xue
Aug 19, 2015·Proceedings of the National Academy of Sciences of the United States of America·Anthony Bowen, Arturo Casadevall
Oct 25, 2012·Pharmacology & Therapeutics·Zhenhua XuHonghui Zhou
Oct 2, 2012·Dermatologic Clinics·Joshua W HagenA Neil Crowson
Jun 19, 2012·The Medical Clinics of North America·Michael GonzalesRomesh Khardori
Mar 5, 2016·Applied Microbiology and Biotechnology·Renate Kunert, David Reinhart
Jul 28, 2015·Human Vaccines & Immunotherapeutics·Xiaomei GengYuanjia Hu
Nov 26, 2015·Frontiers in Immunology·Paul Ostrom KadotaDavid L Perkins
Feb 26, 2016·Expert Opinion on Biological Therapy·Bharath WootlaMoses Rodriguez
Dec 9, 2014·MAbs·Audrey E BakerMark L Chiu
Mar 26, 2009·Diabetes/metabolism Research and Reviews·Adam Kaufman, Kevan C Herold
Jan 16, 2010·Annals of the New York Academy of Sciences·Steven KozlowskiRaymond P Donnelly
Aug 1, 2015·Journal of Medical Radiation Sciences·Clare McKayCaroline Wright
Dec 14, 2004·International Immunopharmacology·Stephen P Cobbold
Jun 3, 2014·European Journal of Microbiology & Immunology·A M Shukra Kapil Maithal
Dec 9, 2014·Frontiers in Immunology·Ellis L Reinherz
Jul 28, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Andra-Sorina TatarSimion Astilean
Sep 30, 2016·Biochemistry. Biokhimii︠a︡·Y L DorokhovT V Komarova
Sep 11, 2016·Current Allergy and Asthma Reports·Hern-Tze Tina TanCezmi A Akdis
Aug 8, 2013·The Journal of Infectious Diseases·Avanish K VarshneyBettina C Fries
Sep 9, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Stephen P Cobbold
Apr 20, 2006·Nature Reviews. Immunology·Paul J Carter
Jul 20, 2002·Transplantation·Michael R Go, Ginny L Bumgardner
Apr 24, 2010·Nature Reviews. Immunology·Andrew C Chan, Paul J Carter
May 23, 2006·Pharmacological Reviews·Ajit S Narang, Ram I Mahato
Jan 16, 2020·Applied Microbiology and Biotechnology·Ziyan WangHuili Lu
Feb 6, 2003·The Journal of Clinical Investigation·Kevan C HeroldJeffrey A Bluestone
Mar 2, 2011·Current Allergy and Asthma Reports·Salvatore ClientiRiccardo Polosa
Jul 13, 1999·Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (NATCO)·T EllingsonT Livesay
Dec 26, 2015·Antibodies·Joanie Del BanoBrigitte Kerfelec
Jun 28, 2016·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Diane R Mould, Bernd Meibohm
Jul 6, 2018·Pharmaceutics·Sahar Awwad, Ukrit Angkawinitwong
Mar 12, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ami PatelDavid B Weiner
Mar 27, 2020·Immunotherapy·Vidhi KhannaThomas S Griffith
Feb 10, 2017·Digestive Diseases and Sciences·Jonathan D Kaunitz
Nov 6, 2018·Frontiers in Immunology·Mathieu DondelingerMarylène S Vandevenne
Mar 1, 2019·Nature Reviews. Rheumatology·Anja S Schmid, Dario Neri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.